GENEVA, March 17 -- TAKEDA PHARMACEUTICAL COMPANY LIMITED (1-1, Doshomachi 4-chome, Chuo-kuOsaka-shi, Osaka 541-0045), APPLEMAN, Vicky (c/o TAKEDA DEVELOPMENT CENTER AMERICAS, INC.500 Kendall StreetCambridge, Massachusetts 02142), HUANG, Harry (c/o TAKEDA DEVELOPMENT CENTER AMERICAS, INC.500 Kendall StreetCambridge, Massachusetts 02142), LINEBERRY, Neil (c/o TAKEDA DEVELOPMENT CENTER AMERICAS, INC.500 Kendall StreetCambridge, Massachusetts 02142), RAIZER, Jeffrey (c/o TAKEDA DEVELOPMENT CENTER AMERICAS, INC.500 Kendall StreetCambridge, Massachusetts 02142), ROSENTRATER, Emily (c/o TAKEDA DEVELOPMENT CENTER AMERICAS, INC.500 Kendall StreetCambridge, Massachusetts 02142) filed a patent application (PCT/IB2025/058946) for "DAZOSTINAG OR CONJUG...